Rossello X, Prescott EIB, Kristensen AMD, Latini R, Fuster V, Fagerland MW, Pocock SJ, Halvorsen S, Dominguez-Rodriguez A, Holmager TLF, Sanchez PL, Bakken A, Raposeiras-Roubin S, Jensen SE, Kimura T, Ottani F, Lambrechtsen J, Anguita M, Ozasa N, Atar D, Ibanez B, Munkhaugen J (2025)
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials
Lancet (in press)
DOI 10.1016/S0140-6736(25)01592-2, PubMed 40897190

Munkhaugen J, Kristensen AMD, Halvorsen S, Holmager T, Olsen MH, Bakken A, Sehested TSG, Ruddox V, Mæng M, Vikenes K, Jensen SE, Steigen T, Lambrechtsen J, Jortveit J, Bovin A, Schirmer H, Christiansen MK, Wiseth R, Mikkelsen D, Larsen AI, Kjærgaard CL, Andresen K, Gustafsson I, Tuseth V, Larsen ML et al. (2025)
Beta-Blockers after Myocardial Infarction in Patients without Heart Failure
N Engl J Med (in press)
DOI 10.1056/NEJMoa2505985, PubMed 40888716

Omland T, Heck SL, Holte E, Mecinaj Lilleaasen A, Gynnild MN, Fagerland MW, Vinje-Jakobsen V, Næs AL, Blix ES, Larsen AI, Geisler J, Gulati G, Wethal T (2025)
Sacubitril-Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial
Circulation (in press)
DOI 10.1161/CIRCULATIONAHA.125.076616, PubMed 40884047